X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (359) 359
Publication (92) 92
Book / eBook (3) 3
Book Chapter (2) 2
Web Resource (2) 2
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (203) 203
male (167) 167
index medicus (129) 129
middle aged (123) 123
aged (117) 117
prostate cancer (117) 117
oncology (105) 105
risk factors (76) 76
cancer (75) 75
article (70) 70
risk (59) 59
prostatic neoplasms - pathology (58) 58
female (57) 57
prostatic neoplasms - prevention & control (54) 54
men (53) 53
research (49) 49
prostate (45) 45
prevention (44) 44
urology & nephrology (43) 43
clinical trials (42) 42
finasteride (41) 41
case-control studies (40) 40
prostate-specific antigen - blood (37) 37
adult (36) 36
aged, 80 and over (35) 35
care and treatment (33) 33
polymorphism, single nucleotide (32) 32
prostatic neoplasms - blood (32) 32
health aspects (31) 31
genetic predisposition to disease (30) 30
prognosis (30) 30
treatment outcome (29) 29
urology (29) 29
biopsy (28) 28
follow-up studies (27) 27
prostatic neoplasms (26) 26
abridged index medicus (25) 25
prostatic neoplasms - epidemiology (25) 25
prostatic neoplasms - mortality (25) 25
finasteride - therapeutic use (24) 24
risk assessment (23) 23
carcinoma (22) 22
prostate-specific antigen (21) 21
radical prostatectomy (21) 21
survival rate (21) 21
prostatic neoplasms - drug therapy (20) 20
public, environmental & occupational health (20) 20
diagnosis (19) 19
genotype (19) 19
proportional hazards models (19) 19
association (18) 18
genome-wide association study (18) 18
neoplasm staging (18) 18
ovarian neoplasms - genetics (18) 18
prostatectomy (18) 18
randomized controlled trials as topic (18) 18
survival (18) 18
survival analysis (18) 18
therapy (18) 18
antigen (17) 17
epidemiology (17) 17
logistic models (17) 17
odds ratio (17) 17
oncology, experimental (17) 17
ovarian cancer (17) 17
prostatic neoplasms - diagnosis (17) 17
prostatic neoplasms - genetics (17) 17
selenium (17) 17
medical and health sciences (16) 16
medicin och hälsovetenskap (16) 16
medicine, general & internal (16) 16
multivariate analysis (16) 16
neoplasm grading (16) 16
prospective studies (16) 16
prostatic neoplasms - surgery (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
disease prevention (15) 15
genome-wide association (15) 15
metaanalysis (15) 15
science (15) 15
analysis (14) 14
biomarkers, tumor - blood (14) 14
chemotherapy (14) 14
double-blind method (14) 14
genomes (14) 14
mortality (14) 14
multidisciplinary sciences (14) 14
trial (14) 14
breast-cancer (13) 13
chemoprevention (13) 13
disease-free survival (13) 13
genes (13) 13
neoplasm metastasis (13) 13
prevention trial (13) 13
time factors (13) 13
vitamin e (13) 13
expression (12) 12
genetic aspects (12) 12
identification (12) 12
metastasis (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA Internal Medicine, ISSN 2168-6106, 10/2019, Volume 179, Issue 10, p. 1440
Journal Article
by Kelemen, Linda E and Earp, Madalene and Fridley, Brooke L and Chenevix-Trench, Georgia and Fasching, Peter A and Beckmann, Matthias W and Ekici, Arif B and Hein, Alexander and Lambrechts, Diether and Lambrechts, Sandrina and Van Nieuwenhuysen, Els and Vergote, Ignace and Rossing, Mary Anne and Doherty, Jennifer A and Chang-Claude, Jenny and Behrens, Sabine and Moysich, Kirsten B and Cannioto, Rikki and Lele, Shashikant and Odunsi, Kunle and Goodman, Marc T and Shvetsov, Yurii B and Thompson, Pamela J and Wilkens, Lynne R and Dörk, Thilo and Antonenkova, Natalia and Bogdanova, Natalia and Hillemanns, Peter and Runnebaum, Ingo B and Bois, Andreas Du and Harter, Philipp and Heitz, Florian and Schwaab, Ira and Butzow, Ralf and Pelttari, Liisa M and Nevanlinna, Heli and Modugno, Francesmary and Edwards, Robert P and Kelley, Joseph L and Ness, Roberta B and Karlan, Beth Y and Lester, Jenny and Orsulic, Sandra and Walsh, Christine and Kjaer, Susanne K and Jensen, Allan and Cunningham, Julie M and Vierkant, Robert A and Giles, Graham G and Bruinsma, Fiona and Southey, Melissa C and Hildebrandt, Michelle A. T and Liang, Dong and Lu, Karen and Wu, Xifeng and Sellers, Thomas A and Levine, Douglas A and Schildkraut, Joellen M and Iversen, Edwin S and Terry, Kathryn L and Cramer, Daniel W and Tworoger, Shelley S and Poole, Elizabeth M and Bandera, Elisa V and Olson, Sara H and Orlow, Irene and Thomsen, Liv Cecilie Vestrheim and Bjorge, Line and Krakstad, Camilla and Tangen, Ingvild L and Kiemeney, Lambertus A and Aben, Katja K. H and Massuger, Leon F. A. G and Van Altena, Anne M and Pejovic, Tanja and Bean, Yukie and Kellar, Melissa and Cook, Linda S and Le, Nhu D and Brooks-Wilson, Angela and Gronwald, Jacek and Cybulski, Cezary and Jakubowska, Anna and Lubiński, Jan and Wentzensen, Nicolas and Brinton, Louise A and Lissowska, Jolanta and Hogdall, Estrid and Engelholm, Svend Aage and Hogdall, Claus and Lundvall, Lene and Nedergaard, Lotte and Pharoah, Paul D. P and Dicks, Ed and Song, Honglin and Tyrer, Jonathan P and McNeish, Iain and Siddiqui, Nadeem and Carty, Karen and Glasspool, Rosalind and ... and Australian Ovarian Canc Study Grp and Ovarian Cancr Assoc Consortium and Australian Ovarian Cancer Study Group and Ovarian Cancer Association Consortium and on behalf of Australian Ovarian Cancer Study Group
International Journal of Molecular Sciences, ISSN 1661-6596, 09/2018, Volume 19, Issue 9, p. 2473
Thymidylate synthase (TYMS) is a crucial enzyme for DNA synthesis. TYMS expression is regulated by its antisense mRNA, ENOSF1. Disrupted regulation may promote... 
Consortia | Enolase superfamily member 1 | Ovarian neoplasms | Gynecology | Genetics | Expression quantitative trait locus | Single-nucleotide polymorphism | Thymidylate synthase | CARBON TRANSFER PATHWAY | RNA | BIOCHEMISTRY & MOLECULAR BIOLOGY | SUSCEPTIBILITY LOCI | thymidylate synthase | consortia | CANCER | CHEMISTRY, MULTIDISCIPLINARY | gynecology | ovarian neoplasms | GENETIC-VARIATION | enolase superfamily member 1 | expression quantitative trait locus | CIGARETTE-SMOKING | genetics | DIFFERENT HISTOTYPES | single-nucleotide polymorphism | EXPRESSION | Genetic Association Studies | Signal Transduction | Adenocarcinoma, Mucinous - pathology | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Thymidylate Synthase - metabolism | Logistic Models | Risk | Thymidylate Synthase - genetics | Case-Control Studies | Ovarian Neoplasms - genetics | Proteins - genetics | Proteins - metabolism | RNA, Antisense - metabolism | Adenocarcinoma, Mucinous - metabolism | Female | Ovarian Neoplasms - metabolism | Polymorphism, Single Nucleotide | Adenocarcinoma, Mucinous - genetics | Odds Ratio | Quantitative Trait Loci | RNA, Antisense - genetics | Statistical analysis | Ovarian carcinoma | Invasiveness | Mucosa | Antisense RNA | Histology | Regression analysis | Gene expression | Esophagus | Independent sample | DNA biosynthesis | Quantitative trait loci | Confidence intervals | Synthesis | Gastrointestinal system | Alleles | Genotypes | Deoxyribonucleic acid--DNA | Tumors | Health care | Sample size | Laboratories | Clinical trials | Oncology | Epidemiology | Ovarian cancer | Research centers | Public health | Age | Preventive medicine | Obstetrics | Meta-analysis | Studies | Pathology | Chemotherapy | Womens health
Journal Article
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 2013, Volume 369, Issue 20, p. 1968
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 14, pp. 1314 - 1325
Despite theoretical benefits of intermittent as compared with continuous androgen-deprivation therapy in patients with metastatic prostate cancer, intermittent... 
MEDICINE, GENERAL & INTERNAL | THERAPY | CLINICAL-TRIAL | FLUTAMIDE | QUALITY-OF-LIFE | SUPPRESSION | CARCINOMA | LEUPROLIDE | Confidence Intervals | Follow-Up Studies | Anilides - adverse effects | Humans | Middle Aged | Male | Gonadotropin-Releasing Hormone - analogs & derivatives | Nitriles - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Metastasis - drug therapy | Penile Erection - drug effects | Gonadotropin-Releasing Hormone - therapeutic use | Goserelin - adverse effects | Prostatic Neoplasms - drug therapy | Goserelin - administration & dosage | Prostatic Neoplasms - pathology | Tosyl Compounds - administration & dosage | Drug Administration Schedule | Antineoplastic Agents, Hormonal - administration & dosage | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Tosyl Compounds - adverse effects | Anilides - administration & dosage | Survival Analysis | Quality of Life | Aged | Androgen Antagonists - administration & dosage | Nitriles - adverse effects | Usage | Care and treatment | Patient outcomes | Androgen suppression therapy | Drug therapy | Prostate cancer | Methods | Cancer | Statistical analysis | Mental disorders | Prostate-specific antigen | Clinical trials | Patients | Survival | Quality of life | Metastases | Androgens | Castration | Stem cells | Luteinizing hormone | Prostate
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 9, pp. 893 - 900
Journal Article
The New England journal of medicine, 05/2019, Volume 380, Issue 20, p. e38
Journal Article
2009, 2nd ed., Current clinical urology, ISBN 1603272801, xvi, 397
More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and... 
Prostate-Specific Antigen | Prostatic Neoplasms | diagnosis | Mass Screening | Health Informatics | Medicine & Public Health | Urology/Andrology | Epidemiology | Medicine/Public Health, general | Medical screening | Prostate
Book
Journal Article
by Kuchenbaecker, Karoline and Ramus, Susan and Tyrer, Jonathan and Lee, Anew and Shen, Howard C and Beesley, Jonathan and Lawrenson, Kate and McGuffog, Lesley and Healey, Sue and Lee, Janet M and Spindler, Tassja J and Lin, Yvonne G and Pejovic, Tanja and Bean, Yukie and Li, Qiyuan and Coetzee, Simon and Hazelett, Dennis and Miron, Alexander and Southey, Melissa and Terry, Mary Beth and Goldgar, David and Buys, Sauna and Janavicius, Ramunas and Dorfling, Cecilia and Rensburg, Elizabeth and Neuhausen, Susan and Ding, Yuan and Hansen, Thomas and Jønson, Lars and Gerdes, Anne-Marie and Ejlertsen, Bent and Barrowdale, Daniel and Dennis, Joe and Benítez, Javier and Osorio, Ana and Garcia, Maria Jose and Komenaka, Ian and Weitzel, Jeffrey and Ganschow, Pamela and Peterlongo, Paolo and Bernard, Loris and Viel, Alessana and Bonnani, Bernardo and Peissel, Bernard and Manoukian, Siranoush and Radice, Paolo and Papi, Laura and Ottini, Laura and Fostira, Florentia and Konstantopoulou, I and Garber, Judy and Frost, Debra and Perkins, Jo and Platte, Radka and Ellis, Steve and Godwin, Anew K and Schmutzler, Rita and Meindl, Alfons and Engel, Christoph and Sutter, Christian and Sinilnikova, Olga and Damiola, Francesca and Mazoyer, Sylvie and Stoppa-Lyonnet, Dominique and Claes, Kathleen B.M and De Leeneer, Kim and Kirk, Judy and Roiguez, Gustavo and Piedmonte, Marion and O'Malley, David M and Hoya, Miguel and Caldes, Trinidad and Aittomäki, Kristiina and Nevanlinna, Heli and Margriet, J. Collée and Rookus, Matti and Oosterwijk, Jan and Tihomirova, Laima and Tung, Nadine and Hamann, Ute and Isaccs, Claudine and Tischkowitz, Marc and Imyanitov, Evgeny and Caligo, Maria and Campbell, Ian and Hogervorst, Frans and Olah, E and Díez, Orland and Blanco, Ignacio and Brunet, Joan and Lazaro, Conxi and Pujana, Miguel and Jakubowska, Anna and Gronwald, Jacek and Lubinski, Jan and Sukiennicki, Grzegorz and Barkardottir, Rosa and Plante, Marie and Simard, Jacques and Soucy, Penny and ... and KConFab Investigators and EMBRACE and GEMO Study Collaborators and Breast Cancer Family Registry and Australian Ovarian Canc Study Grp and HEBON and Consortium Invest Modifiers BRCA1 and Australian Canc Study Ovarian Canc and Australian Cancer Study (Ovarian Cancer Investigators) and Australian Ovarian Cancer Study Group and Consortium of Investigators of Modifiers of BRCA1 and BRCA2 and the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 and Region Östergötland and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Diagnostikcentrum and Klinisk patologi och klinisk genetik and Avdelningen för kliniska vetenskaper and Hälsouniversitetet
Nature Genetics, ISSN 1061-4036, 01/2015, Volume 47, Issue 2, pp. 164 - 171
Journal Article